Malcova
Malcova, Inc
Discover Malcova's advanced, painless Narrow-Beam CT technology designed for precise early detection of breast cancer and stroke, empowering radiologists and improving patient outcomes.
malcova.com · Newark, CA
Funding event
The round itself, as filedInferred stagePre-seed
Sold of offered$1.2M of $2.0M
Filed2026-09-08
Days since filing25
- Exemption claimed
- Rule 506(b)
- First-ever Form D
- Yes
- Date of first sale
- 2026-08-24
Investors
No investors named: Form D does not list them
Officers on the filing
Names and roles as filed; addresses are never stored- Peymon GhaziExecutive Officer · Director
- Tara GhaziExecutive Officer · Director
- Moushmi SolejaDirector
Health flags
Three flags, each with the raw inputs behind it · as of 2026-10-03UndersubscribedNot flagged60.7% sold1.3 months since first sale
Prior raiseNot flaggedPrior raise not known—
AmendedNot flaggedNo amendmentNo D/A on file
Open roles
On the employer's own careers page · checked 2026-09-210
Pre-posting windowNot enough dataShown once this sector and stage have 20 observed lags from filing to first posting.
No open roles foundWe read careers pages daily.
Also raised in Health & bio
Same sector, 28 days to 2026-10-04Altay TherapeuticsSeries A · $15.7M of $45.1M · San Carlos, CAQuietCarebilitySeries A · $8.8M of $8.8M · Richardson, TXQuiet
75 rounds in Health & bio in the 28 days to 2026-10-02, against 71 in the 28 days before.